Filana Therapeutics, Inc. Loss Contingency Accrual, Provision
Filana Therapeutics, Inc. (FLNA) reported Loss Contingency Accrual, Provision of $35.25 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Loss Contingency Accrual, Disclosures
us-gaap:LossContingencyAccrualProvision · last filed 2026-03-12
- Filana Therapeutics, Inc. loss contingency accrual, provision for the quarter ending 2025-12-31 was $0.00.
- Filana Therapeutics, Inc. loss contingency accrual, provision for the quarter ending 2025-09-30 was $0.00.
- Filana Therapeutics, Inc. loss contingency accrual, provision for the quarter ending 2025-06-30 was $32.25M.
- Filana Therapeutics, Inc. loss contingency accrual, provision for the quarter ending 2025-03-31 was $3.00M.
- Filana Therapeutics, Inc. loss contingency accrual, provision for fiscal 2025 was $35.25M.
| Period end | Loss Contingency Accrual, Provision 3 month | Loss Contingency Accrual, Provision 6 month | Loss Contingency Accrual, Provision 9 month | Loss Contingency Accrual, Provision 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $32.25M derived: sum of 3 quarters · filed 2026-03-12 | $35.25M 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $32.25M derived: sum of 2 quarters · filed 2025-11-12 | $35.25M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $32.25M 10-Q · filed 2025-08-14 | $35.25M 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $3.00M derived: 10-K 12 month − 3 quarters · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |